Indian Journal of Pharmacy Practice
Volume 6, Issue 1
2013 · pp. 1–87 · 14 articles
- Volume
- 6
- Issue
- 1
- Published
- 2013
- Pages
- 1–87
- Articles
- 14
- Sections
- 1
- ISSN
- Online - 0974-8326
- Journal
- IJOPP
In this issue
Association of Pharmaceutical Teachers of India
- Article
Mahendrakumar BJ, Sowmya M, Uma Maheswari D, Hymavathi R, Ramesh S
pp. 1–5
Formulary is a continually revised compilation of pharmaceuticals and some important ancillary information that reflects the current clinical judgement of medical staff. The main reason for developing hospital formulary …
- Article
Tarun W, Patil P.A, Suresh V P
pp. 6–12
Adverse drug reaction (ADR) has been considered as a major threat to healthcare. Many studies continue to explore the incidence, causality and preventability of ADRs in different setup of healthcare so as to minimize or …
- Article
Asawari R, Atmaram P, Kushal G, Aeyna T
pp. 13–18
The purpose of this study was to assess the appropriateness in glucocorticoid prescribing with respect to selection, dose, duration and route of therapy to prevent therapeutic failure or occurrence of glucocorticoid asso…
- Article
Rekha B, Saurabh B
pp. 19–24
Background:Medication error is recognized as the eighth leading cause of death. Objective: The study was proposed to evaluate the prevalence and types of medication errors in IPD (In-patient department) at multispecialty…
- Article
Rasna J, Bijoy C V, Feba B, Geetha K, Vijayakumar A
pp. 25–30
Chemotherapy induced alopecia is the most distressing feature in cancer treatment. The technique of continuous cooling of scalp during chemotherapy reduces the temperature of scalp and causes vasoconstriction of blood ve…
- Article
Anila K N, Emmanuel J
pp. 31–35
The study was conducted to find the magnitude of impact of a clinical pharmacist in improving knowledge of cardiology patients about oral anticoagulants. The interventional group received an additional care by the clinic…
- Article
Mahendrakumar B J, Soumya M, Jagadish B D, PraveenKumar M, Varun S C
pp. 36–40
Tobacco use is one of the major risk factor for 6 out of 8 leading causes of death in the world.It has been estimated that there are 1.1 billion smokers worldwide and 182 million (16.6%) of them live in India. It has bee…
- Article
Vigneshwaran E, Padmanabha RY, Devanna N
pp. 41–46
HIV/AIDS is a chronic disease and the patients are frequently prescribed with multiple long term therapy where it requires educating the patients regarding their disease and about the drugs for an effective management. P…
- Article
Vivek J, Priya R, Shubhi P, Shilpi R, Preeti S, Ashuthosh P, Yashumati R, Nishant P
pp. 47–58
Introduction:The present study was design to investigate the level of job satisfaction and social identity among the pharmacist working in rural area of India. Method:Prepared questionnaire for pharmacist job satisfactio…
- Article
Arun A E, Kannan K, ShobhaRani RH, Sundaresh K N, Shekar H S, Ramjan S
pp. 59–68
Objective:To do a pilot study to understand the study habits of the post-graduation (PG) pharmacy practice students in India and their perspective on the use of a Learning Management System (LMS) in line with the current…
- Article
Manjusha S, Vandana N, Goutham R, Sneha M, Atmaram P.P
pp. 69–73
Eclampsia is a common obstetric emergency associated with significant maternal and fatal morbidity and mortality rate. The aim is to evaluate incidence, management, perinatal & maternal morbidity/ mortality associated wi…
- Article
Sanket S.S, Anand I.S
pp. 74–79
The objective of the study was to measure efficacy and safety of Rosuvastatin-10mg versus Atorvastatin-20mg in patients with Hypercholesterolemia. We conducted a single centre retrospective study, involving 117 hyperchol…
- Article
Vinay P, Krishna S N, Narayana G, Jaffar S, Dixon T
pp. 80–81
This is a case report focusing on a 50 year old woman's death possibly due to Filgrastim. Filgrastim is considered to be a drug of choice in neutropenic cases. But in this case, Filgrastim has developed several severe ad…
- Article
Sajida S, Jaffar S M, Balaji K, Narayana G
pp. 82–83
This is a case report focusing on a 62 years male patient who experienced complete loss of vision after the intra ocular administration of known strength of Bevacizumab. Bevacizumab is the choice of drug in the treatment…